A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
for AML (Acute Myelogenous Leukemia)
13 locations incl. Birmingham
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All·Age: 18 - 66
Code: NCT06859424·Phase 2·Recruiting